PHAXIAM Therapeutics Competitors and Similar CompaniesClear all
PHAXIAM Therapeutics's competitors and similar companies include Aeglea and Genentech.
 PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |
Founding Date | Founding Date 2004 | Founding Date 2013 | Founding Date 1976 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations Austin, US HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 49 | Employees 65117% increase | Employees 18,077 |
Valuation ($) | Valuation ($) 52.8 m | Valuation ($) 48.6 m | Valuation ($) N/A |
Financial | |||
Net income | Net income (€23.5m) (FY, 2023) | Net income ($155.2m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company